CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System
NCT03013868
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Circulating Tumor Cells, CTC
Sponsor
MiCareo Taiwan Co., Ltd.